Skip to main content
SpringerLink
Log in

Irinotecan trials indicate progress at last in colorectal cancer

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

Results from new trials suggest that irinotecan improves response rates in patients with previously untreated colorectal cancer when added to conventional fluorouracil chemotherapy. The results, presented at the 35th Annual Meeting of the American Society of Clinical Oncology [ Atlanta, US; May 1999 ], herald progress at last in the treatment of advanced colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Carmen Innes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Innes, C. Irinotecan trials indicate progress at last in colorectal cancer. Inpharma Wkly. 1197, 13–14 (1999). https://doi.org/10.2165/00128413-199911970-00021

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199911970-00021

Keywords

Search

Navigation